Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded 'No longer looking for participants', indicating enrollment has paused or ended. The history also shows Revision: v3.6.0 and removes Revision: v3.5.5 from the log.SummaryDifference0.4%

- Check10 days agoChange DetectedThe record history now shows Revision: v3.5.5, updating the metadata to reflect the latest history entry. It replaces the previous revision stamp.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.4 was added to the Study Record History and Revision: v3.5.3 was removed. This reflects an update to the page's revision metadata in the history section.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site/version change rather than a modification to the clinical trial record itself.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded Revision: v3.5.2 to the history. Removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Revision: v3.5.0 in the record history. Removed Revision: v3.4.3 from the record history.SummaryDifference0.1%

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.